Literature DB >> 18806804

How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?

Christoph Koenen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18806804     DOI： 10.1038/ncpendmet0972

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  2 in total

1.  Response to Swinnen et al.

Authors:  Alan C Moses; Christoph Koenen
Journal:  Diabetes Technol Ther       Date:  2010-06       Impact factor: 6.118

2.  A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.

Authors:  Sanne G Swinnen; Marie-Paule Dain; Ronnie Aronson; Melanie Davies; Hertzel C Gerstein; Andreas F Pfeiffer; Frank J Snoek; J Hans Devries; Joost B Hoekstra; Frits Holleman
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 17.152
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.